UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Real-world clinical effectiveness of once-weekly semaglutide in patients with type 2 diabetes: a systematic literature review Journal article
Zhen Ruan, Yixuan Jiang, Honghao Shi, Ruxu Jia, Carolina Oi Lam Ung, Hao Hu. Real-world clinical effectiveness of once-weekly semaglutide in patients with type 2 diabetes: a systematic literature review[J]. Expert Review of Clinical Pharmacology, 2023, 16(2), 161-176.
Authors:  Zhen Ruan;  Yixuan Jiang;  Honghao Shi;  Ruxu Jia;  Carolina Oi Lam Ung; et al.
Favorite | TC[WOS]:5 TC[Scopus]:5  IF:3.6/4.1 | Submit date:2023/08/03
Effectiveness  Glp-1ra  Hba1c  O.w. Semaglutide  Type 2 Diabetes  Real-world Evidence  Review  Weight  
Differential HbA1c response in the placebo arm of DPP-4 inhibitor clinical trials conducted in China compared to other countries: A systematic review and meta-analysis Journal article
He L., Liu S., Shan C., Tu Y., Li Z., Zhang X.D.. Differential HbA1c response in the placebo arm of DPP-4 inhibitor clinical trials conducted in China compared to other countries: A systematic review and meta-analysis[J]. BMC Pharmacology and Toxicology, 2016, 17(1).
Authors:  He L.;  Liu S.;  Shan C.;  Tu Y.;  Li Z.; et al.
Favorite | TC[WOS]:4 TC[Scopus]:5 | Submit date:2018/12/21
Diabetes Mellitus  Differential Hba1c Response  Dipeptidyl Peptidase-4 Inhibitor  Meta-analysis  T2dm